Darius Dian1, Visnja Drinovac, Ioannis Mylonas, Klaus Friese. 1. Department of Obstetrics and Gynaecology, University Hospital Munich, Campus Innenstadt, Maistrasse 11, 80337, Munich, Germany. darius.dian@med.uni-muenchen.de
Abstract
PURPOSE: Breast reconstructions are made autologously, that is with the body's own tissue, or heterologously by means of implants. This either causes donor site morbidity or a foreign body is implanted. Both are disadvantages which could not be avoided up to now. By using tissue of the still remaining (contralateral) breast both could be avoided. The object of this paper is to check whether this technique is feasible. METHOD: By dividing the existing breast and transferring it to the contralateral side, we were able to successfully conduct a single-procedure breast reconstruction with one female patient. RESULTS: The operation technique as well as the post-operative progression of the female patient will be presented. CONCLUSION: Mamma-splitting is a new and promising method of reconstruction with own tissue, without donor site morbidity or implant. The use within a bigger group of female patients will show the method's validity.
PURPOSE: Breast reconstructions are made autologously, that is with the body's own tissue, or heterologously by means of implants. This either causes donor site morbidity or a foreign body is implanted. Both are disadvantages which could not be avoided up to now. By using tissue of the still remaining (contralateral) breast both could be avoided. The object of this paper is to check whether this technique is feasible. METHOD: By dividing the existing breast and transferring it to the contralateral side, we were able to successfully conduct a single-procedure breast reconstruction with one female patient. RESULTS: The operation technique as well as the post-operative progression of the female patient will be presented. CONCLUSION: Mamma-splitting is a new and promising method of reconstruction with own tissue, without donor site morbidity or implant. The use within a bigger group of female patients will show the method's validity.